MEHNAZ KHAN: Open Payments
NPI 1841411873 · SHERMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$319 in 22 payments from 5 companies in 2025. Trend: 2023 $1,011 · 2024 $442 · 2025 $319
Food & beverage: $319
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $158 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| Abbott Laboratories | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, COBENFY, PROCLAIM, REXULTI.
Industry payments across TX — which companies pay providers there.
